Abstract
Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Três Braços, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6/62 (10%), mucosal relapse after cutaneous infection in 2/62 (3%), and mucosal relapse after mucosal disease in 2/17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible.
| Original language | English |
|---|---|
| Pages (from-to) | 367-370 |
| Number of pages | 4 |
| Journal | Transactions of the Royal Society of Tropical Medicine and Hygiene |
| Volume | 84 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 1990 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime®'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver